Birth length and weight as predictors of breast cancer prognosis

The median time interval from the initial diagnosis of breast cancer was 57 months (range 1 – 384 months) and the median time interval from metastatic disease, irrespective of site,

Using publicly available databases, we found that GREM1 is also expressed on mRNA level by various human breast cancer cell lines and that GREM1 is significantly upregulated in

We also observe that weight gain during breast cancer treatment may be associated with decreased acylcarnitines, lyso-phosphatidylcholines, phosphatidylcholines

This NWAS involved investigation of intakes of 92 foods and nutrients (for which data were available) in relation to breast cancer risk in the European Prospective Inves- tigation

Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: A new role for g protein-coupled estrogen receptor in mediating

Our analysis on breast cancer patients undergoing breast surgery for IBTR, CBC and REC provides two main re- sults: (1) the DM dynamics following a new breast surgi- cal

Conclusions: FGD5 is a new prognostic marker in breast cancer, and increased copy number is associated with higher tumour proliferation and poorer long-term prognosis.. Key

1 Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening program (To-Be): a randomized, controlled trial.. Tomosynthesis